Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2011 Aug 4;10(10):1939–1948. doi: 10.1158/1535-7163.MCT-11-0228

Table 1b. Structures of Candidate Compounds.

The structures for the 13 candidate compounds are shown.

No Compound Structure
1 Andrographolide graphic file with name nihms316498t1.jpg
2 4′-Hydroxychalcone graphic file with name nihms316498t2.jpg
3 Cycloheximide graphic file with name nihms316498t3.jpg
4 Doxazosin mesylate graphic file with name nihms316498t4.jpg
5 7-Desoxypurpurogalli n-7-carboxylic acid, methylester, trimethlyester graphic file with name nihms316498t5.jpg
6 Carboplatin graphic file with name nihms316498t6.jpg
7 Gitoxin graphic file with name nihms316498t7.jpg
8 Acetylglucosamine graphic file with name nihms316498t8.jpg
9 Oxyphenbutazone graphic file with name nihms316498t9.jpg
10 Quinacrine graphic file with name nihms316498t10.jpg
11 Ellipticine graphic file with name nihms316498t11.jpg
12 Acriflavinium hydrochloride graphic file with name nihms316498t12.jpg
13 Rutilantinone graphic file with name nihms316498t13.jpg